Katrin Sproesser
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Melanoma and MAPK Pathways 5
- Advanced biosensing and bioanalysis techniques 2
- Oncology 7
- CAR-T cell therapy research 3
- Cancer Cells and Metastasis 2
- Co-authors
- Meenhard Herlyn (8 shared papers)Katherine L. Nathanson (2 shared papers)Patricia Brafford (4 shared papers)Clemens Krepler (3 shared papers)Min Xiao (2 shared papers)Stefan Torborg (1 shared paper)Abhyudai Singh (1 shared paper)Margaret C. Dunagin (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cancer Immunology Immunotherapy (2 papers)Cancer Research (2 papers)European Journal of Cancer (1 paper)Melanoma Research (1 paper)
- Partner nations
- United StatesTunisiaAustralia
In The Last Decade
Katrin Sproesser
16 papers receiving 1.2k citations
Katrin Sproesser's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 399
- Cancer Research 203
- Molecular Biology 902
- Biophysics 73
- Immunology 169
Countries citing papers authored by Katrin Sproesser
This map shows the geographic impact of Katrin Sproesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Sproesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Sproesser more than expected).
Fields of papers citing papers by Katrin Sproesser
This network shows the impact of papers produced by Katrin Sproesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Sproesser. The network helps show where Katrin Sproesser may publish in the future.
Co-authors
The 25 scholars most cited alongside Katrin Sproesser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance Hit paper breakdown → | 2017 | 771 |
| 2 | 2008 | 186 | |
| 3 | 2010 | 124 | |
| 4 | 2020 | 36 | |
| 5 | 2007 | 34 | |
| 6 | 2016 | 24 | |
| 7 | 2003 | 19 | |
| 8 | 2017 | 15 | |
| 9 | 2013 | 5 | |
| 10 | 2003 | 3 | |
| 11 | 2006 | 3 | |
| 12 | The novel MEK1/2 inhibitor AZD6244 (ARRY-142886) inhibits the growth of melanomas harboring the BRAF V600E mutation in vitro and in vivo | 2007 | 2 |
| 13 | 2016 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2020 | 1 |
About Katrin Sproesser
Katrin Sproesser is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Cell Biology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (3 papers), melanin and skin pigmentation (2 papers), Cancer Cells and Metastasis (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (399 citations), Cancer Research (203 citations), Molecular Biology (902 citations), Biophysics (73 citations) and Immunology (169 citations). Katrin Sproesser has collaborated with scholars based in United States, Tunisia and Australia. Frequent co-authors include Meenhard Herlyn, Katherine L. Nathanson, Patricia Brafford, Clemens Krepler, Min Xiao, Stefan Torborg, Abhyudai Singh, Margaret C. Dunagin, Eduardo A. Torre and Benjamin Emert. Their work appears in journals such as Clinical Cancer Research, Cancer Immunology Immunotherapy, Cancer Research, European Journal of Cancer and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.